AI Verdict
LLY has stronger fundamentals based on our AI analysis.
LLY vs VRTX Fundamental Comparison
| Metric | LLY | VRTX |
|---|---|---|
| Revenue | $65.2B | $12.0B |
| Net Income | $20.6B | $4.0B |
| Net Margin | 31.7% | 32.9% |
| ROE | 77.8% | 21.2% |
| ROA | 18.4% | 15.4% |
| Current Ratio | 1.58x | 2.90x |
| Debt/Equity | 1.54x | 0.01x |
| EPS | $22.95 | $15.32 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LLY vs VRTX: Frequently Asked Questions
Is LLY or VRTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LLY has stronger fundamentals. LLY is rated BUY (90% confidence) while VRTX is rated BUY (86% confidence). This is not investment advice.
How does LLY compare to VRTX fundamentally?
ELI LILLY & Co has ROE of 77.8% vs VERTEX PHARMACEUTICALS INC / MA's 21.2%. Net margins are 31.7% vs 32.9% respectively.
Which stock pays higher dividends, LLY or VRTX?
LLY has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LLY or VRTX for long term?
For long-term investing, consider that LLY has BUY rating with 90% confidence, while VRTX has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LLY vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LLY vs VRTX, the AI consensus favors LLY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.